Chris Anderson is a bioengineering researcher and educator. He received his Ph.D. in 2003 from the Scripps Research Institute for expanding the genetic code through genetic engineering. Currently he is a professor in the Department of Bioengineering at UC Berkeley. His research focuses on foundational technologies and applications of synthetic biology, a ground-up approach to genetic engineering with diverse applications in healthcare, environmental remediation, bioenergy, chemicals and materials production. Chris is best known for his ongoing work on developing therapeutic bacteria for the treatment of cancer for which he was recognized with Technology Review's TR35 award in 2007.